Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Industry News
Search Articles:
CymaBay Therapeutics announces seladelpar granted Breakthrough Therapy Designation by FDA
CymaBay Therapeutics announced the FDA has granted Breakthrough Therapy Designation for seladelpar for treatment of early stage primary biliary cholangitis in combination with ursodeoxycholic acid in adult patients with an inadequate response to UDCA.
February 15, 2019
More...
Email This Page
to a Friend
Print This
Page